# FDA Inspection 1083809 - Daewoo Pharmaceutical Co., Ltd. - February 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/daewoo-pharmaceutical-co-ltd/40184655-bb6d-4841-a92c-085de30c05e5
Source feed: FDA_Inspections

> FDA Inspection 1083809 for Daewoo Pharmaceutical Co., Ltd. on February 22, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1083809
- Company Name: Daewoo Pharmaceutical Co., Ltd.
- Inspection Date: 2019-02-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258203 - 2025-01-15](https://www.keypedia.com/records/fda_inspections/daewoo-pharmaceutical-co-ltd/50a9d2be-e7f9-4486-993c-dbb45b74eac3)
- [FDA Inspection 1258203 - 2025-01-15](https://www.keypedia.com/records/fda_inspections/daewoo-pharmaceutical-co-ltd/ceb4bcdf-d411-482c-a9aa-957dc615b70d)
- [FDA Inspection 1009230 - 2017-03-28](https://www.keypedia.com/records/fda_inspections/daewoo-pharmaceutical-co-ltd/b12c557e-cbb4-4a90-b581-84babb6d154a)

Company: https://www.keypedia.com/companies/daewoo-pharmaceutical-co-ltd/440e3629-5661-4fac-bc0e-71ae7f78f63b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c